Focus
Acta Pharmaciae Indonesia is a peer-reviewed scientific journal committed to publishing original research and review articles that advance knowledge and innovation in pharmaceutical sciences and related disciplines. The journal promotes rigorous, ethical, and evidence-based research concerning the discovery, development, evaluation, and use of medicines.

Scope
The journal invites original research and review articles in, but not limited to, the following areas:
• Pharmaceutical Technology and Drug Delivery: Drug formulation, dosage forms, drug delivery systems, pharmaceutical nanotechnology, and formulation evaluation.
• Pharmacology and Toxicology: Pharmacological mechanisms, biological activities, drug safety, and toxicological evaluation.
• Pharmaceutical Chemistry and Drug Discovery: Medicinal chemistry, drug design, synthesis, bioinformatics-guided drug discovery, and general drug discovery.
• Pharmacognosy and Natural Products: Medicinal plants, phytochemistry, natural product isolation, and bioactivity evaluation.
• Pharmaceutical Analysis and Quality Control: Analytical method development and validation, drug stability, quality assurance, and pharmaceutical quality assessment.
• Clinical and Social Pharmacy: Clinical pharmacy, pharmaceutical care, medication safety, pharmacoeconomics, pharmacoepidemiology, and pharmacy practice.
• Pharmacokinetics and Pharmacodynamics: Drug disposition, pharmacokinetic modeling, dose optimization, and exposure–response relationships.
• Biopharmaceutics and Pharmaceutical Biotechnology: Drug absorption and bioavailability, biological drug systems, and biotechnology-based pharmaceutical development.
• Regulatory Affairs and Pharmaceutical Policy: Drug regulation, pharmaceutical legislation, access to medicines, and evidence-based pharmaceutical policy.

Publication Criteria
All submissions must demonstrate scientific relevance, originality, methodological rigor, appropriate research ethics, and compliance with the journal's editorial policies. Manuscripts are evaluated based on their scientific quality and contribution to pharmaceutical sciences, regardless of the authors' geographic location. Only manuscripts that align with the journal's scope and meet its editorial and ethical requirements will be considered for peer review.